ADTX
Aditxt Inc

17,997
Mkt Cap
$420,118.00
Volume
12.74M
52W High
$53,451.08
52W Low
$0.4747
PE Ratio
0.00
ADTX Fundamentals
Price
$0.5149
Prev Close
$1.22
Open
$0.79
50D MA
$13.91
Beta
0.78
Avg. Volume
147,771.89
EPS (Annual)
-$31,153.51
P/B
-0.00
Rev/Employee
$122.89
$1.60
Loading...
Loading...
News
all
press releases
Nasdaq Down 200 Points; Brady Earnings Top Views
US stocks lower as Nasdaq falls 200 points, Dow down 0.04% and S&P 500 down 0.37%. Energy shares up 1.8%, tech stocks down 1.6%. Brady Corp reports strong earnings. Sunshine Biopharma, Virax Biolabs...
News Placeholder
More News
News Placeholder
ADTX Stock Crashes Over 20% After Third Reverse Split In 7 Months – Retail Calls The Decline ‘Unreasonable’
Aditxt announced a 1-for-27 reverse stock split to maintain compliance with Nasdaq’s listing rules.
News Placeholder
Financial Lp Hrt Acquires 72,912 Shares of Aditxt (NASDAQ:ADTX) Stock
Aditxt, Inc. (NASDAQ:ADTX - Get Free Report) major shareholder Financial Lp Hrt bought 72,912 shares of the firm's stock in a transaction that occurred on Tuesday, April 21st. The stock was bought at...
News Placeholder
Dana-Farber Cancer Institute Study Demonstrates Predictive Value of Ignite Proteomics RPPA Platform for T-DXd (Enhertu) Therapy in Metastatic Breast Cancer Patients
Aditxt, Inc. (Nasdaq: ADTX) (Aditxt or the Company), a social innovation platform accelerating promising health innovations, today announced that its precision oncology subsidiary, Ignite Proteomics...
News Placeholder
Aditxt Subsidiary Ignite Proteomics Appoints Public Company Veteran Jeff Busch as Chief Executive Officer
Aditxt, Inc. (Nasdaq: ADTX) (Aditxt or the Company), a social innovation platform accelerating promising health innovations, today announced the appointment of Jeff Busch as Chief Executive Officer...
News Placeholder
Aditxt Acquires Ignite Proteomics to Address a Critical Challenge in Cancer Care: Optimizing Therapy Selection
Aditxt, Inc. (NASDAQ: ADTX) (Aditxt or the Company), a social innovation platform accelerating promising health innovations, today announced the acquisition of Ignite Proteomics, LLC (Ignite), a...
News Placeholder
Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-8 Reverse Stock Split Effective at the Open of Trading on March 9, 2026
Aditxt, Inc. (Nasdaq: ADTX) (Aditxt or the Company), a social innovation platform accelerating promising health innovations, announced today that it will effect a 1-for-8 reverse split of its common...
News Placeholder
Why Aditxt Shares Are Trading Higher By Around 63%; Here Are 20 Stocks Moving Premarket
read more...
News Placeholder
What Sparked Aditxt (ADTX) Stock's 52% After Hours Surge?
Aditxt shares surged 52% after hours following the company's filing of a definitive proxy statement for a special stockholder meeting in January 2026.read more...
News Placeholder
Promising Penny Stocks To Consider - November 30th
Bitfarms, Pasithea Therapeutics, Aditxt, Tilray Brands, Beyond Meat, Data Knights Acquisition, and Bit Digital are the seven Penny stocks to watch today, according to MarketBeat's stock screener...
<
1
2
...
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available